期刊文献+

氧化偶氮甲烷和葡聚糖硫酸钠致肠炎相关性结直肠癌小鼠模型的建立 被引量:2

Establishment of AOM / DSS induced a mice model of colitis associated cancer
下载PDF
导出
摘要 目的:建立肠炎相关性结直肠癌的小鼠模型。方法:给予小鼠单次小剂量腹腔注射氧化偶氮甲烷(azoxymethane,AOM)联合2%葡聚糖硫酸钠(dextran sodium sulpate,DSS)自由饮用,建立肠炎相关性结直肠癌小鼠模型。对照组小鼠给予PBS腹腔注射后普通饮水。每天观察症状,2%DSS 5 d,普通饮水16 d,此21 d为1个循环,共进行4个循环,结束后,断颈处死小鼠,取脾脏、肠系膜淋巴结、结肠,观察并比较两组小鼠脾脏,肠系膜淋巴结大体改变和结肠HE染色情况。结果:与对照组比较,实验组小鼠脾脏、肠系膜淋巴结明显增大,结肠远端出现肿瘤。HE染色结果显示,实验组发病小鼠结肠黏膜层及黏膜下层出现广泛的炎症细胞浸润,腺体组织结构紊乱、破坏,出现腺管样结构,具有组织异型性。结论:单剂量AOM与DSS联合使用可在短期内诱导小鼠结肠肿瘤的发生。 Objective: To establish a mice model of colitis associated cancer. Methods: The colitis associated cancer was induced by a single intraperitoneal injection of 12. 5 mg / kg azoxymethane( AOM) and stepped by four cycles oral administration of 2% dextran sodium sulpate( DSS). The occult blood was observed everyday. At the end of the fouth cycle,the mice were killed for observing the spleen,mesenteric lymph nodes,colon; colon tissues were harvested for mucosa morphological changes under light microscopy. Results: Compared to the control group,the spleens,mesenteric lymph nodes were enlarged and the tumorigenesis was found in distal colon in the experiment group; and there were a lot of inflammation cell infiltration and dysplasia in colon. Conclusion: Administration of AOM combined with DSS could induce a mice model of colorectal cancer in a short period.
出处 《江苏大学学报(医学版)》 CAS 2015年第1期19-21,共3页 Journal of Jiangsu University:Medicine Edition
基金 国家自然科学基金资助项目(31170849) 江苏省自然科学基金资助项目(BK2011472)
关键词 氧化偶氮甲烷 葡聚糖硫酸钠 结肠癌 动物模型 azoxymethane dextran sodium sulpate colorectal cancer animal model
  • 相关文献

参考文献7

  • 1Scott V Adams,Dennis J Ahnen,John A Baron,Peter T Campbell,Steven Gallinger,William M Grady,Loic LeMarchand,Noralane M Lindor,John D Potter,Polly A Newcomb.Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry[J].World Journal of Gastroenterology,2013,19(21):3241-3248. 被引量:2
  • 2Jessica K Dyson,Matthew D Rutter.Colorectal cancer in inflammatory bowel disease:What is the real magnitude of the risk?[J].World Journal of Gastroenterology,2012,18(29):3839-3848. 被引量:25
  • 3Seung Joon Baek,Ryuji Okazaki,Seong-Ho Lee,Jeanelle Martinez,Jong-Sik Kim,Kiyoshi Yamaguchi,Yuji Mishina,David W. Martin,Ahmed Shoieb,Michael F. Mcentee,Thomas E. Eling.Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 Over Expression in Transgenic Mice Suppresses Intestinal Neoplasia[J]. Gastroenterology . 2006 (5)
  • 4Denis E. Corpet,Fabrice Pierre.How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men[J]. European Journal of Cancer . 2005 (13)
  • 5Christoph Becker,Massimo C. Fantini,Christoph Schramm,Hans A. Lehr,Stefan Wirtz,Alexei Nikolaev,Jürgen Burg,Susanne Strand,Ralf Kiesslich,Samuel Huber,Hiroaki Ito,Norihiro Nishimoto,Kazuyuki Yoshizaki,Tadamitsu Kishimoto,Peter R. Galle,Manfred Blessing,Stefan Rose-John,Markus F. Neurath.TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans -Signaling[J]. Immunity . 2004 (4)
  • 6Alexandros Papanikolaou,Ronald C. Shank,Don A. Delker,Andrew Povey,Donald P. Cooper,Daniel W. Rosenberg.Initial Levels of Azoxymethane-Induced DNA Methyl Adducts Are Not Predictive of Tumor Susceptibility in Inbred Mice[J]. Toxicology and Applied Pharmacology . 1998 (1)
  • 7Daniel W. Rosenberg,Ying Liu.Induction of aberrant crypts in murine colon with varying sensitivity to colon carcinogenesis[J]. Cancer Letters . 1995 (2)

二级参考文献16

  • 1Martha L. Slattery,Roger K. Wolff,Jennifer S. Herrick,Bette J. Caan,John D. Potter.IL6 genotypes and colon and rectal cancer[J].Cancer Causes & Control.2007(10)
  • 2Dr. Jonathan A. Heerden M.B., F.R.C.S.(C),Robert W. Beart M.D.Carcinoma of the colon and rectum complicating chronic ulcerative colitis[J].Diseases of the Colon & Rectum.1980(3)
  • 3Eaden JA,Abrams KR,Mayberry JF.The risk of colorectal cancer in ulcerative colitis: a meta-analysis[].Gut.2001
  • 4Itzkowitz SH,Yio X.Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation[].American Journal of Physiology Gastrointestinal and Liver Physiology.2004
  • 5O’’connor PM,Lapointe TK,Beck PL, et al.Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease[].Inflammatory Bowel Diseases.2010
  • 6CD Gillen,RS Walmsley,P Prior,HA Andrews,RN Allan.Ulcerative colitis and Crohn’s disease: a comparison of the colorectal cancer risk in extensive colitis[].Gut.1994
  • 7Danese S,Mantovani A.Inflammatory bowel disease and intestinal cancer:a paradigm of the Yin-Yang interplay between inflammation and cancer[].Oncegene.2010
  • 8Erlinger TP,Platz EA,Rifai N,et al.C-reactive protein and risk ofincident colorectal cancer[].Journal of the American Medical As-sociation.2004
  • 9KK Tsilidis,C Branchini,E Guallar,KJ Helzlsouer,TP Erlinger,EA Platz.C-reactive protein and colorectal cancer risk: a systematic review of prospective studies[].International Journal of Cancer.2008
  • 10Flossmann E,Rothwell PM.Effect of aspirin on long-term risk of colorectal cancer:consistent evidence from randomised and observational studie[].The Lancet.2007

共引文献28

同被引文献14

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部